Acetaminophen intake and risk of asthma, hay fever and eczema in early adolescence

Iranian Journal of Allergy, Asthma and Immunology

Volumn 6, Issue 3, 2007, Pages 143-149

  Vlaski, Emilija ^a   Stavric, Katerina ^a   Isjanovska, Rozalinda ^b   Seckova, Lidija ^a   Kimovska, Milica ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Macedonia)

^b Institute of Epidemiology and Biostatistics   (Macedonia)

Author keywords

Acetaminophen; Adolescent; Asthma; Atopic eczema; Hay fever

Indexed keywords

PARACETAMOL;

ADOLESCENT; ADOLESCENT HEALTH; ALLERGIC DISEASE; ARTICLE; ASTHMA; ATOPIC DERMATITIS; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG USE; HAY FEVER; HUMAN; MACEDONIA (REPUBLIC); MAJOR CLINICAL STUDY; RHINOCONJUNCTIVITIS; RISK FACTOR;

ACETAMINOPHEN; ADOLESCENT; ASTHMA; ECZEMA; FEMALE; HUMANS; MACEDONIA (REPUBLIC); MALE; PREVALENCE; QUESTIONNAIRES; RHINITIS, ALLERGIC, SEASONAL; RISK FACTORS;

EID: 35848931651     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Masoli M, Fabian D, Holt S, Beasley R for the Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004; 59(5):469-78.
2. Strachan DP, Sibbald B, Weiland SK, Ait-Khaled N, Anabwani G, Anderson HR, et al. Worldwide variation in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997; 8(4):161-76.
3. Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103(1 pt 1):125-38.
4. Vlaski E, Stavric K, Isjanovska R, Seckova L, Kostovski A, Kimovska M. Prevalence and severity of asthma, allergic rhinitis and eczema in school children in Skopje (International Study of Asthma and Allergies in Childhood phase 3). Macedonian Journal of Medicine 2005; 51:24-34.
5. Vlaski E, Stavric K, Isjanovska R, Seckova L, Kimovska M. Overweight hypothesis in asthma and eczema in young adolescents. Allergol Immunopathol (Madr) 2006; 34(5):199-205.
6. Newson RB, Shaheen SO, Chinn S, Burney PG. Paracetamol sales and atopic disease in children and adults: an ecological analysis. Eur Respir J 2000; 16(5):817-23.
7. Shaheen SO, Newson RB, Sherriff A, Henderson AJ, Heron JE, Burney PG, et al. Paracetamol use in pregnancy and wheezing in early childhood. Thorax 2002; 57(11):958-63.
8. Shaheen SO, Newson RB, Henderson AJ, Headley JE, Stratton FD, Jones RW, et al. ALSPAC Study Team. Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood. Clin Exp Allergy 2005; 35(1):18-25
9. Shaheen SO, Sterne JA, Songhurst CE, Burney PG. Frequent paracetamol use and asthma in adults. Thorax 2000; 55(4):266-70.
10. Eneli I, Sadri K, Camargo C, Barr RG. Acetaminophen and the risk of asthma: the epidemiologic and pathophysiologic evidence. Chest 2005; 127(2):604-12.
11. Varner AE, Busse WW, Lemanske RF Jr. Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma. Ann Allergy Asthma Immunol 1998; 81(4):347-51.
12. Varner A. Paracetamol and asthma. Thorax 2000; 55(10):882-3
13. Allmers H. Frequent acetaminophen use and allergic diseases: is the association clear? J Allergy Clin Immunol 2005; 116(4):859-62.
14. Shaheen SO, Sterne JAC, Thompson RL, Songhurst CE, Margetts BM, Burney PG. Dietary antioxidants and asthma in adults: population-based case-control study. Am J Respir Crit Care Med 2001; 164(10 Pt 1):1823-8
15. Fogarty A, Davey G. Paracetamol, antioxidants and asthma. Clin Exp Allergy 2005; 35(6):700-2.
16. Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW, on behalf of the ISAAC Steering Committee and the ISAAC Phase Three Study Group. ISAAC Phase Three Manual. Auckland, New Zealand: ISAAC International Data Centre, 2000.
17. Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW, and the ISAAC Steering Committee. The International Study of Asthma and Allergies in Childhood (ISAAC): Phase Three rationale and methods. Int J Tuberc Lung Dis 2005; 9(1):10-6.
18. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12:315-35.
19. ISAAC Phase Three Newsletter. Auckland, New Zealand, December 2001.
20. Cohet C, Cheng S, MacDonald C, Baker M, Foliaki S, Huntington N, et al. Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood. J Epidemiol Community Health 2004; 58(10):852-7.
21. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics 2002; 109(2):E20.
22. Davey G, Berhane Y, Duncan P, Aref-Adib G, Britton J, Venn A. Use of acetaminophen and the risk of self-reported allergic symptoms and skin sensitization in Butajira, Ethiopia. J Allergy Clin Immunol 2005; 116(4):863-8.
23. Barr GR, Wentowski CC, Curhan CG, Somers CS, Stampfer JM, Schwartz J, et al. Prospective study of acetaminophen use and newly diagnosed asthma among women. Am J Respir Crit Care Med 2004; 169(7):836-41.
24. McKeever TM, Lewis SA, Smit HA, Burney P, Britton JR, Cassano PA. The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function. Am J Respir Crit Care Med 2005; 171(9):966-71.
25. Karakaya G, Lakyoncu AF. Paracetamol and asthma. Expert Opin Pharmacother 2003; 4(1):13-21.
26. GINA Workshop Report. Global Strategy for Asthma Management and Prevention. NIH Publication No 02-3659, Updated 2005. Available from URL: http://ginasthma.org.
27. Dimova S, Hoet PH, Dinsdale D, Nemery B. Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro. Int J Biochem Cell Biol 2005; 37(8):1727-37.
28. Nuttall SL, Khan JN, Thorpe GH, Langford N, Kendall MJ. The impact of therapeutic doses of paracetamol on serum total antioxidant capacity. J Clin Pharm Ther 2003; 28(4):289-94.
29. Kozer E, Evans S, Barr J, Greenberg R, Soriano I, Bulkowstein M, et al. Glutathione, glutathione-dependent enzymes and antioxidant status in erythrocytes from children treated with high dose paracetamol. Br J Clin Pharmacol 2003; 55(3):234-40.
30. Worldwide variations in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351(9111):1225-32.